Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Bases de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
J Pediatr Endocrinol Metab ; 25(5-6): 441-5, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22876536

RESUMO

Our study aimed to assess uterine development in Turner syndrome patients and its relation to dose and type of estrogen therapy; and karyotype. Pelvic ultrasound was used to assess uterine size and shape, and ovarian volume in 40 Turner syndrome patients. Information on hormone replacement therapy was collected from patients' notes. Among the 40 patients studied, 57.5% started estrogen therapy and 30% were taking progestins. Sixty-five per cent had immature uterus, 17.5% had fully mature uterus and 17.5% had transitional uterus. Uterine volume was associated with age (p < 0.001), height (p = 0.002), weight (p = 0.001), years of estrogen use (p < 0.001), estrogen dose (p = 0.016), current estrogen use ( p =0.001) and Tanner breast stage ( p <0.001). Uterine volume was not affected by the type of estrogen used ( p =0.40) and karyotype ( p =0.40). Patients with Turner syndrome treated with estrogen (of adequate dose and duration) may attain a normal, mature uterine size and configuration, even at a late start of hormone replacement therapy and regardless of karyotype.


Assuntos
Estrogênios/administração & dosagem , Terapia de Reposição Hormonal/métodos , Progestinas/administração & dosagem , Síndrome de Turner/tratamento farmacológico , Síndrome de Turner/patologia , Útero/crescimento & desenvolvimento , Cariótipo Anormal , Adolescente , Adulto , Criança , Estudos Transversais , Relação Dose-Resposta a Droga , Feminino , Humanos , Resultado do Tratamento , Síndrome de Turner/genética , Ultrassonografia , Útero/diagnóstico por imagem , Útero/efeitos dos fármacos , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA